Skip to main content
SupplementScience

Benefits of Kava

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Anxiety reduction (Cochrane level evidence) — Pittler & Ernst (2003) systematically reviewed 11 RCTs in the Cochrane Database and concluded kava extract significantly reduced anxiety compared to placebo, with a weighted mean difference of 3.9 points on the Hamilton Anxiety Scale
  • Generalized anxiety disorder — Sarris et al. (2013) conducted a rigorous 6-week RCT of 75 patients with GAD, finding 120-240mg kavalactones daily (titrated based on response) significantly reduced anxiety compared to placebo, with a remission rate of 26% vs 6% for placebo
  • Multi-target anxiolytic mechanism — kavalactones modulate GABA-A receptors (kavain), block voltage-gated sodium channels (reducing neuronal excitability), inhibit norepinephrine reuptake, and modulate MAO-B activity, providing broad-spectrum anxiety relief through complementary pathways
  • Cognitive preservation — unlike benzodiazepines, kava does not impair cognitive function at therapeutic doses. Sarris et al. found no cognitive side effects, and some studies suggest mild cognitive enhancement alongside anxiety reduction
  • Muscle relaxation — kavalactones have direct skeletal muscle relaxant properties, providing physical relaxation that complements the psychological anxiolytic effects, beneficial for tension-type anxiety and stress-related muscle tension

What the Research Says

Kava has the strongest evidence base among herbal anxiolytics. The Cochrane review by Pittler & Ernst (2003) analyzed 11 RCTs totaling 645 participants and found kava significantly superior to placebo for anxiety (WMD 3.9 on Hamilton Anxiety Scale). Sarris et al. (2013) confirmed this in a well-designed 6-week RCT showing significant GAD symptom reduction with kavalactones. Regarding safety, the hepatotoxicity concern stems from case reports primarily linked to non-noble cultivars, use of stem and leaf material (not root), and ethanol/acetone extraction methods. Teschke et al. (2012) comprehensively reviewed the liver safety data and concluded that noble cultivar aqueous root extracts have an excellent safety profile, consistent with centuries of traditional Pacific Island use without liver toxicity.

Related Conditions

StressSleep
Full Kava Guide

References

  1. (). Kava extract for treating anxiety. Cochrane Database of Systematic Reviews. DOI
  2. (). Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. Journal of Clinical Psychopharmacology. DOI
  3. (). Kava hepatotoxicity solution: a six-point plan for new kava standardization. Phytomedicine. DOI
  4. (). Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Australian and New Zealand Journal of Psychiatry. DOI